Hot flushes, joint pain and fatigue on fulvestrant

Fulvestrant works by attaching to oestrogen receptors on breast cancer cells and breaking them down, so the cancer can no longer use oestrogen to grow. The same receptors are found in other parts of the body, including the brain areas that control temperature, the joints, the bones and the vaginal tissues. Blocking them can bring on symptoms similar to the menopause. The ones people mention most often are hot flushes and sweats, joint and muscle aches, and tiredness. Many people also notice headaches, feeling sick or a lower mood at times. For most, these effects are mild to moderate, and they often ease after the first few months as the body adjusts. They are usually milder than the side effects of chemotherapy, and hair loss is uncommon. It is worth remembering that fulvestrant is often given alongside another medicine, such as a CDK4/6 inhibitor like palbociclib, ribociclib or abemaciclib, and that the cancer itself, low blood counts, poor sleep or low vitamin D can all add to tiredness and aches. Sorting out which cause is most likely helps your team choose the right approach. There are many non-hormonal ways to ease hot flushes, keep joints moving and manage fatigue, and most people can continue treatment with support.

These effects are common

Hot flushes, aches and tiredness are among the side effects listed most often for fulvestrant. Having them does not mean something has gone wrong.

They often ease with time

Many people find symptoms are strongest in the first months and then settle to a level they can live with.

Other causes are worth checking

New or severe bone pain, tiredness with breathlessness, or low mood that will not lift should be discussed, as they may have another cause.

Most people can manage these symptoms, but it helps to be realistic about what relief looks like.

Relief is usually partial

Non-hormonal options tend to reduce hot flushes rather than stop them. Joint aches often improve with activity but may not go away entirely.

Hormone replacement is generally avoided

Taking oestrogen would work against the treatment, so hormone replacement therapy is not usually advised for hormone receptor positive breast cancer.

Side effects do not show whether treatment works

Having strong symptoms, or none at all, does not tell you how well fulvestrant is controlling the cancer. Scans and check-ups do that.

What this page cannot tell you

It cannot tell you which cause lies behind your own tiredness or pain. Your team can examine you and arrange tests.

Fulvestrant is often paired with a targeted tablet. The partner medicine can add its own side effects, which sometimes look similar.

CDK4/6 inhibitors

Palbociclib, ribociclib and abemaciclib commonly cause tiredness, largely linked to lower blood counts. Abemaciclib more often causes loose motions.

Other targeted tablets

Alpelisib and capivasertib can cause raised blood sugar, rash and loose motions, which also affect energy.

Why it matters

Working out which medicine is responsible guides the fix. A dose change to the tablet, rather than stopping fulvestrant, is often all that is needed.